Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains

Lin Guo(Thomas Jefferson University), James Shorter(University of Pennsylvania), Jack D. Rubien(University of Pennsylvania), Emma Robinson(Thomas Jefferson University), Jiazhen Xu(University of Pittsburgh), Alessandra Chesi(Stanford University), Bo Lim Lee(University of Pennsylvania), Amanda M. Gleixner(University of Pittsburgh), Hejia Wang(Bloomberg (United States)), Ashleigh Smirnov(University of Pennsylvania), Christopher J. Donnelly(University of Pittsburgh), Jacob R. Mann(University of Pittsburgh), Marilyn Ngo(University of Pittsburgh), Carolann Espy(Translational Therapeutics (United States)), Eric J. Huang(Broad Center), Yulei Shang(Broad Center), Katie E. Copley(University of Pennsylvania), Jessica Merjane(University of Pittsburgh), Hana M. Odeh(University of Pennsylvania), JiaBei Lin(University of Pennsylvania), Bede Portz(University of Pennsylvania), George M. Padilla(University of Pennsylvania), Sua Myong(Boston Children's Hospital), Jenny Carey(Thomas Jefferson University), Nicolas L. Fawzi(Brown University), Laura R. Ganser(Johns Hopkins University), Jocelyn C. Mauna(University of Pittsburgh), Zamia Diaz(University of Pennsylvania), Kevin M. Kim(Thomas Jefferson University), Anastasia C. Murthy(Brown University), Ellen Lavorando(University of Pennsylvania), Tapas Paul(Johns Hopkins University), Cristian A Bergmann(Universidad Mayor)
Molecular Cell
January 1, 2026
Cited by 6


Related Papers